脂蛋白、脂质组与肠道菌群变化在持续性炎症、免疫抑制和分解代谢综合征发病中的作用:一项前瞻性队列研究
该前瞻性队列研究纳入ICU患者,于入科第1天和第7天采集血与粪便样本,用液相色谱串联质谱分析脂质组、16S RNA测序评估肠道菌群,探讨脂蛋白、脂质组与肠道菌群在PIICS病理生理中的作用。后续发生PIICS的患者高密度脂蛋白、低密度脂蛋白及其他脂蛋白水平低于未发生PIICS者。PIICS-2较PIICS-1多数脂质和肠道微生物显著减少。第7天高密度脂蛋白水平可预测PIICS诊断与预后,并与炎症标志物水平及30天生存相关。作者认为脂代谢与肠道菌群在PIICS发生中存在相互作用,微生物介导的脂代谢调控是PIICS的潜在治疗靶点。
要点
- 后续发生PIICS的ICU患者高密度脂蛋白、低密度脂蛋白及其他脂蛋白水平低于未发生PIICS者。
- PIICS-2较PIICS-1多数脂质和肠道微生物显著减少,提示脂质组与菌群动态变化与PIICS相关。
- 入科第7天高密度脂蛋白水平可预测PIICS诊断与预后,并与炎症标志物水平及30天生存相关。
- 作者认为脂代谢与肠道菌群在PIICS发生中存在相互作用,微生物介导的脂代谢调控是潜在治疗靶点。
适用人群与场景
- 纳入ICU收治的患者,入科第1天和第7天采集血与粪便样本。
研究设计与关键结果
- 研究类型为前瞻性队列研究,纳入ICU患者,于入科第1天和第7天采集血和粪便样本。
- 脂质组采用液相色谱串联质谱分析,肠道菌群组成采用16S RNA测序评估。
- 后续发生PIICS的患者高密度脂蛋白、低密度脂蛋白及其他脂蛋白水平低于未发生PIICS者。
- PIICS-2较PIICS-1多数脂质和肠道微生物显著减少。
- 入科第7天高密度脂蛋白水平可预测PIICS诊断与预后,并与炎症标志物水平及30天生存相关。
证据类型、等级与局限
- 证据类型为前瞻性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为脂代谢与肠道菌群在PIICS发生中存在相互作用,微生物介导的脂代谢调控是PIICS的潜在治疗靶点。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Persistent inflammation, immunosuppression, and catabolism syndrome (PIICS) is a severe condition that occurs in patients in intensive care units (ICUs), and it is associated with high morbidity and mortality. This prospective cohort study investigated the dynamic changes in lipoproteins, lipidomics, and gut microbiota from days 1 to 7 posthospitalization for PIICS to elucidate their roles in the pathophysiology of PIICS. Patients admitted to the ICU were enrolled, and blood and fecal samples were collected 1 day and 7 days after admission. Lipidomic profiles were analyzed using liquid chromatography with tandem mass spectrometry, and gut microbiota composition was assessed using 16S RNA sequencing Patients who subsequently developed PIICS had lower levels of high-density lipoprotein, low-density lipoprotein, and other lipoproteins than those in patients without PIICS. Most of the lipids and gut microbes decreased significant in PIICS-2 compared to PIICS-1. Day 7 high-density lipoprotein levels were predictive of PIICS diagnosis and prognosis, and were correlated with inflammatory marker levels and 30-day survival. These findings suggest an interplay between lipid metabolism and gut microbiota in PIICS development; therefore, microbiota-mediated regulation of lipid metabolism is a potential therapeutic target for PIICS. This study provides novel insights into the complex mechanisms underlying PIICS and highlights the importance of further research into targeted interventions for critically ill patients with this syndrome.
参考来源
- Chen X, Li H, Huang S, et al. ROLE OF CHANGES IN LIPOPROTEINS, LIPIDOMES, AND GUT MICROBIOTA IN THE PATHOGENESIS OF PERSISTENT INFLAMMATION, IMMUNOSUPPRESSION, AND CATABOLISM SYNDROME: A PROSPECTIVE COHORT STUDY. Shock. 2025. PMID: 40844181. doi:10.1097/SHK.0000000000002634
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。